Feeding the heat on brown fat

Annals of the New York Academy of Sciences

Volumn 1302, Issue 1, 2013, Pages 11-23

  Sellayah, Dyan ^a   Sikder, Devanjan ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

Brown fat; Feeding; Hormone; Orexin; Thermogenesis

Indexed keywords

OREXIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR;

ARTICLE; BROWN ADIPOSE TISSUE; CALORIC INTAKE; ENERGY EXPENDITURE; FEEDING; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; HYPOPHAGIA; LEAN BODY WEIGHT; LIPOLYSIS; NONHUMAN; OBESITY; PATHOGENESIS; SIGNAL TRANSDUCTION; THERMOGENESIS; WEIGHT GAIN;

RODENTIA;

EID: 84885907756     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12276     Document Type: Article

References (90)

1. Melnikova, I. & D. Wages. 2006. Anti-obesity therapies. Nat. Rev. Drug Discov. 5: 369-370.
2. Tseng, Y.H., A.M. Cypess & C.R. Kahn. 2010. Cellular bioenergetics as a target for obesity therapy. Nat. Rev. Drug Discov. 9: 465-482.
3. Blaxter, K. 1989. Energy Metabolism in Animals and Man. Cambridge: Cambridge University Press.
4. Leibel, R.L., M. Rosenbaum & J. Hirsch. 1995. Changes in energy expenditure resulting from altered body weight. N. Engl. J. Med. 332: 621-628.
5. Virtanen, K.A. et al. 2009. Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360: 1518-1525.
6. van Marken Lichtenbelt, W.D. et al. 2009. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360: 1500-1508.
7. Tseng, Y.H. et al. 2008. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454: 1000-1004.
8. Whittle, A.J. 2012. Searching for ways to switch on brown fat: are we getting warmer? J. Mol. Endocrinol. 49: R79-R87.
9. Wu, J. et al. 2012. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150: 366-376.
10. Petrovic, N. et al. 2010. Chronic peroxisome proliferator-activated receptor γ (PPARγ) activation of epididymally derived white adipocyte cultures reveals a population of thermogenically competent, UCP1-containing adipocytes molecularly distinct from classic brown adipocytes. J. Biol. Chem. 285: 7153-7164.
11. Seale, P. et al. 2008. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454: 961-967.
12. Cannon, B. & J. Nedergaard. 2010. Thyroid hormones: igniting brown fat via the brain. Nat. Med. 16: 965-967.
13. Guerra, C. et al. 2001. Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J. Clin. Investig. 108: 1205-1213.
14. Kajimura, S. et al. 2009. Initiation of myoblast to brown fat switch by a PRDM16-C/EBP-[bgr] transcriptional complex. Nature 460: 1154-1158.
15. Nedergaard, J., T. Bengtsson & B. Cannon. 2011. New powers of brown fat: fighting the metabolic syndrome. Cell Metab. 13: 238-240.
16. Scimè, A. et al. 2005. Rb and p107 regulate preadipocyte differentiation into white versus brown fat through repression of PGC-1α. Cell Metab. 2: 283-295.
17. Gautvik, K.M. et al. 1996. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc. Natl. Acad. Sci. U.S.A. 93: 8733-8738.
18. de Lecea, L. et al. 1998. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 95: 322-327.
19. Sakurai, T. et al. 1998. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585.
20. Kotz, C.M., J.A. Teske, J.A. Levine & C. Wang. 2002. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul. Pept. 104: 27-32.
21. Haynes, A.C. et al. 2000. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Pept. 96: 45-51.
22. Sellayah, D., P. Bharaj & D. Sikder. 2011. Orexin is required for brown adipose tissue development, differentiation, and function. Cell Metab. 14: 478-490.
23. Hara, J., C.T. Beuckmann & T. Nambu. 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30: 345-354.
24. Lin, L. et al. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98: 365-376.
25. Chemelli, R.M. et al. 1999. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451.
26. Willie, J.T. et al. 2003. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 38: 715-730.
27. Connolly, H.M. et al. 1997. Valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med. 337: 581-588.
28. Nishino, S. et al. 2000. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355: 39-40.
29. Thannickal, T.C. et al. 2000. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27: 469-474.
30. Nishino, S. et al. 2001. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol. 50: 381-388.
31. Hallmayer J. et al. 2009. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat. Genet. 41: 708-711.
32. Matsuki, K. et al. 1992. DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet 339: 1052.
33. Cvetkovic-Lopes, V. et al. 2010. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J. Clin. Investig. 120: 713-719.
34. Cave, H. 1931. Narcolepsy. Arch. Neurol. Psychiatr. 50-101.
35. Daniels, L. 1934. Narcolepsy. Medicine 13: 1-122.
36. Kotagal, S., K. Hartse & J.K. Walsh. 1990. Characteristics of narcolepsy in preteenaged children. Pediatrics 85: 205-209.
37. Bell, I. 1976. Diet Histories in Narcolepsy. New York: Spectrum.
38. Schuld, A., J. Hebebrand, F. Geller & T. Pollmächer. 2000. Increased body-mass index in patients with narcolepsy. Lancet 355: 1274-1275.
39. Schuld, A. et al. 2002. Increased body mass index (BMI) in male narcoleptic patients, but not in HLA- DR2-positive healthy male volunteers. Sleep Med. 3: 335-339.
40. Dahmen, N., J. Bierbrauer & M. Kasten. 2001. Increased prevalence of obesity in narcoleptic patients and relatives. Eur. Arch. Psychiatry Clin. Neurosci. 251: 85-89.
41. Kok, S.W. et al. 2003. Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity. Obesity 11: 1147-1154.
42. Lammers, G.J. et al. 1996. Spontaneous food choice in narcolepsy. Sleep 19: 75-76.
43. Middelkoop, H.A. et al. 1995. Circadian distribution of motor activity and immobility in narcolepsy: assessment with continuous motor activity monitoring. Psychophysiology 32: 286-291.
44. Adam, J.A. et al. 2002. Decreased plasma orexin-A levels in obese individuals. Int. J. Obes. Relat. Metab. Disord. 26: 274-276.
45. Baranowska, B. et al. 2005. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women. Neuro. Endocrinol. Lett. 26: 293-296.
46. Smart, D., A.C. Haynes, G. Williams & J.R. Arch. 2002. Orexins and the treatment of obesity. Eur. J. Pharmacol. 440: 199-212.
47. Knutson, K. & E. Van Cauter. 2008. "Associations between sleep loss and increased risk of obesity and diabetes." In "Molecular and Biophysical Mechanisms of Arousal, Alertness, and Attention." D.W. Pfaff & B.L. Kieffer, Eds. Ann. N. Y. Acad. Sci. 1129: 287-304.
48. Bronský, J. et al. 2007. Dynamic changes of orexin A and leptin in obese children during body weight reduction. Physiol. Res. 56: 89-96.
49. Golozoubova, V. et al. 2001. Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold. FASEB J. 15: 2048-2050.
50. Cannon, B. & J. Nedergaard. 2004. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84: 277-359.
51. Sellayah, D. & D. Sikder. 2012. Orexin-receptor 1 mediates brown fat developmental differentiation. Adipocyte 1: 58-63.
52. Bachman, E.S. et al. 2002. Beta AR signaling required for diet-induced thermogenesis and obesity resistance. Science 297: 843-845.
53. Tateishi, K., Y. Okada, E.M. Kallin & Y. Zhang. 2009. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458: 757-761.
54. Liu, X., M. Rossmeisl, J. McClaine & L.P. Kozak. 2003. Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J. Clin. Investig. 111: 399-407.
55. Bamshad, M., C.K. Song & T.J. Bartness. 1999. CNS origins of the sympathetic nervous system outflow to brown adipose tissue. Am. J. Physiol. 276: R1569-R1578.
56. Yasuda, T. et al. 2005. Dual regulatory effects of orexins on sympathetic nerve activity innervating brown adipose tissue in rats. Endocrinology 146: 2744-2748.
57. Cerri, M. & S.F. Morrison. 2005. Activation of lateral hypothalamic neurons stimulates brown adipose tissue thermogenesis. Neuroscience 135: 627-638.
58. Shirasaka, T., T. Kunitake, M. Takasaki & H. Kannan. 2002. Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions. Regul. Pept. 104: 91-95.
59. Monda, M. et al. 2004. Injection of orexin A into the diagonal band of Broca induces symphatetic and hyperthermic reactions. Brain Res. 1018: 265-271.
60. Symonds, M. et al. 2003. Endocrine and nutritional regulation of fetal adipose tissue development. J. Endocrinol. 179: 293-299.
61. Alexander, G. & D. Stevens. 1980. Sympathetic innervation and the development of structure and function of brown adipose tissue: studies on lambs chemically sympathectomized in utero with 6-hydroxydopamine. J. Dev. Physiol. 2: 119-137.
62. Nakabayashi, M. et al. 2003. Orexin-A expression in human peripheral tissues. Mol. Cell. Endocrinol. 205: 43-50.
63. Reznikoff, C.A., D.W. Brankow & C. Heidelberger. 1973. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 33: 3231-3238.
64. Tang, Q.-Q., T. C. Otto & M.D. Lane. 2004 Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc. Natl. Acad. Sci. U.S.A. 101: 9607-9611.
65. Funato, H. et al. 2009. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab. 9: 64-76.
66. Peyron, C. et al. 2009. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6: 991-997.
67. Kastin, A.J. & V. Akerstrom. 1999. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J. Pharmacol. Exp. Ther. 289: 219-223.
68. Tupone, D., C.J. Madden, G. Cano & S.F. Morrison. 2011. An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. J. Neurosci. 31: 15944-15955.
69. Whittle, Andrew J. et al. 2012. Bmp8b increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 149: 871-885.
70. Verty, A.N.A., A. M. Allen & B.J. Oldfield. 2010. The endogenous actions of hypothalamic peptides on brown adipose tissue thermogenesis in the rat. Endocrinology 151: 4236-4246.
71. Sieber, C., J. Kopf, C. Hiepen & P. Knaus. 2009 Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 20: 343-355.
72. Liu, Y. et al. 2009. Serotonin induces Rho/ROCK-dependent activation of Smads 1/5/8 in pulmonary artery smooth muscle cells. FASEB J. 23: 2299-2306.
73. Ross, J.J. et al. 2001. Twisted gastrulation is a conserved extracellular BMP antagonist. Nature 410: 479-483.
74. Bragdon, B. et al. 2011. Bone morphogenetic proteins: a critical review. Cell. Signal. 23: 609-620.
75. Jiao, X. et al. 2007. Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J. Biol. Chem. 282: 1080-1086.
76. Warbrick-Smith, J. et al. 2006. Evolving resistance to obesity in an insect. Proc. Natl. Acad. Sci. U.S.A. 103: 14045-14049.
77. Warwick, P.M. & R. Busby. 1990. Influence of mild cold on 24 h energy expenditure in 'normally' clothed adults. Br. J. Nutr. 63: 481-488.
78. Thompson, M.D. et al. 2004. Variants of the orexin2/hcrt2 receptor gene identified in patients with excessive daytime sleepiness and patients with Tourette's syndrome comorbidity. Am. J. Med. Genet. B Neuropsychiatr. Genet. 129B: 69-75.
79. Mishima K.F.N. et al. 2008. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy. Sleep 31: 1119-1126.
80. Deadwyler, S.A., L. Porrino, J.M. Siegel & R.E. Hampson. 2007. Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J. Neurosci. 27: 14239-14247.
81. Celi, F.S. et al. 2010. Minimal changes in environmental temperature result in a significant increase in energy expenditure and changes in the hormonal homeostasis in healthy adults. Eur. J. Endocrinol. 163: 863-872.
82. van Ooijen, A.M.J., M.J. Claessens-van, et al. 2006. Heat production and body temperature during cooling and rewarming in overweight and lean men. Obesity 14: 1914-1920.
83. van Ooijen, A.M.J., W.D. van Marken Lichtenbelt & K.R. Westerterp. 2001. Individual differences in body temperature and the relation to energy expenditure: the influence of mild cold. J. Therm. Biol. 26: 455-459.
84. Li, M.F. & B.M. Cheung. 2011. Rise and fall of anti-obesity drugs. World J. Diabetes 2: 19-23.
85. Bartelt, A. et al. 2011. Brown adipose tissue activity controls triglyceride clearance. Nat. Med. 17: 200-205.
86. Cannon, B. & J. Nedergaard. 2010. Metabolic consequences of the presence or absence of the thermogenic capacity of brown adipose tissue in mice (and probably in humans). Int. J. Obes. 34: S7-S16.
87. Bronnikov, G. et al. 1999. β1 to β3 switch in control of cyclic adenosine monophosphate during brown adipocyte development explains distinct β-adrenoceptor subtype mediation of proliferation and differentiation. Endocrinology 140: 4185-4197.
88. Novak, C.M. & J.A. Levine. 2009. Daily intraparaventricular orexin-A treatment induces weight loss in rats. Obesity 17: 1493-1498.
89. Yamanaka, A. et al. 1999. Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight. Brain Res. 849: 248-252.
90. Ehrström, M. et al. 2005. Inhibitory effect of exogenous orexin A on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man. J. Clin. Endocrinol. Metab. 90: 2370-2377.